The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Abstract
Background— Circulating levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) are elevated in diabetic patients. We assessed the role of glucose in the regulation of circulating levels of IL-6, TNF-α, and interleukin-18 (IL-18) in subjects with normal or impaired glucose tolerance (IGT), as well as the effect of the antioxidant glutathione. Methods and Results— Plasma glucose levels were acutely raised in 20 control and 15 IGT subjects and maintained at 15 mmol/L for 5 hours while endogenous insulin secretion was blocked with octreotide. In control subjects, plasma IL-6, TNF-α, and IL-18 levels rose ( P <0.01) within 2 hours of the clamp and returned to basal values at 3 hours. In another study, the same subjects received 3 consecutive pulses of intravenous glucose (0.33 g/kg) separated by a 2-hour interval. Plasma cytokine levels obtained at 3, 4, and 5 hours were higher ( P <0.05) than the corresponding values obtained during the clamp. The IGT subjects had fasting plasma IL-6 and TNF-α levels higher ( P <0.05) than those of control subjects. The increase in plasma cytokine levels during the clamping lasted longer (4 hours versus 2 hours, P <0.01) in the IGT subjects than in the control subjects, and the cytokine peaks of IGT subjects after the first glucose pulse were higher ( P <0.05) than those of control subjects. On another occasion, 10 control and 8 IGT subjects received the same glucose pulses as above during an infusion of glutathione; plasma cytokine levels did not show any significant change from baseline after the 3 glucose pulses. Conclusions— Hyperglycemia acutely increases circulating cytokine concentrations by an oxidative mechanism, and this effect is more pronounced in subjects with IGT. This suggests a causal role for hyperglycemia in the immune activation of diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, a negative influence of postprandial hypertriglyceridemia on endothelial function has been reported in both normal and diabetic subjects.”
In the citing paper
“Other studies have demonstrated that fluctuations in blood glucose levels may contribute more to outcomes than constant high blood glucose concentrations.31–35”
From Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020) · cites this paper as [32]
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Cited by
Sorted by citations
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
“Inflammatory cytokines are also acutely increased by hyperglycaemi”
BackgroundInflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Shared Risk Factors in Cardiovascular Disease and Cancer
Koene, R. J., Prizment, A. E., Blaes, A. H., & Konety, S. (2016) · Circulation · doi:10.1161/circulationaha.115.020406 · Cited by 1,512
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414
“And particularly cogent is the recent finding that acute hyperglycemia in nondiabetic and IGT subjects elevates plasma IL-6 and TNF- concentrations, higher and longer in individuals with IGT and when the glucose was given as pulses (126).”
BackgroundCeriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
“In humans, moderate elevation of glucose to 270 mg/dl (15 mmol/l) for 5 h has been associated with increased IL-6, IL-18, and TNF- (62).”
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice
Rozanski, A., Blumenthal, J. A., Davidson, K. W., Saab, P. G., & Kubzansky, L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.005 · Cited by 1,238
“he potential mechanism for this association may be comlex, involving not only stimulation of the HPA axis and the ympathetic nervous system but also potential synergy inuced by peripheral effects, such as hyperglycemia (62).”
BackgroundOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,284
Breaking Up Prolonged Sitting Reduces Postprandial Glucose and Insulin Responses
Dunstan, D. W., Kingwell, B. A., Larsen, R., Healy, G. N., Cerin, E., Hamilton, M. T., Shaw, J. E., Bertovic, D. A., Zimmet, P. Z., Salmon, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1931 · Cited by 1,203
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
“Also, reverse causality should be considered, as recent studies have shown that hyperglycemia, by producing oxidative stress, is itself proinflammatory (40).”
BackgroundPostprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
“Studies support the evidence that an acute hyperglycemia during a hyperglycemic clamp (56) or in the postprandial state (57) can increase the production of plasma interleukin-6, tumor necrosis factor- , and interleukin-18.”
BackgroundSelf-citationThe Effects of Diet on Inflammation
Giugliano, D., Ceriello, A., & Esposito, K. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.052 · Cited by 842
Self-citationObesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S. M., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 831
Cawthorn, W. P., & Sethi, J. K. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.051 · Cited by 833
“Additionally, oxidative stress may promote increased production of TNF-a under adverse metabolic conditions [103].”
BackgroundRole of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
Oguntibeju, O. O. (2019) · Europe PMC (PubMed Central) · Cited by 758
Rodbard, H. W., Blonde, L., Ss, B., Brett, E. M., Cobin, R. H., Handelsman, Y., Hellman, R., Jellinger, P. S., Jovanovic, L. G., Levy, P., et al. (2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 695
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 655
“In addition, in older diabetic patients with poor glycemic control and asymptomatic individuals with abnormal fasting glycemia, thiobarbituric acid-reactive substances a marker of oxidative stress, and IL-6 levels are independently correlated with C-reactive protein, suggesting that oxidative stress promotes a state o…”
BackgroundCirculating Mononuclear Cells in the Obese Are in a Proinflammatory State
Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P., & Dandona, P. (2004) · Circulation · doi:10.1161/01.cir.0000142055.53122.fa · Cited by 611
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M. P., Salvatore, T., Galiero, R., Rinaldi, L., Vetrano, E., Marfella, R., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080420 · Cited by 579
Self-citationOxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia
Wright, E., Scism-Bacon, J. L., & Glass, L. C. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00825.x · Cited by 517
“antioxidant) in control and IGT patients completely suppressed cytokine elevation in response to intermittent glucose pulses, supporting the concept that an oxidative stress mechanism mediates the inflammatory effect of hyperglycaemia in humans ( 27 ).”
BackgroundInfluentialEndoplasmic Reticulum Stress in Immunity
Bettigole, S. E., & Glimcher, L. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112116 · Cited by 523
Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men
de Koning, L., Malik, V. S., Kellogg, M. D., Rimm, E. B., Willett, W. C., & Hu, F. B. (2012) · Circulation · doi:10.1161/circulationaha.111.067017 · Cited by 503
Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects
Turina, M., Fry, D. E., & Polk, H. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000170106.61978.d8 · Cited by 491
“The administration of recombinant IL-6 has been shown to induce hyperglycemia and compensatory hyperinsulinemia, two biological markers of insulin resistance (66, 84).”
BackgroundHyperglycemia and Acute Coronary Syndrome
DEEDWANIA, P. C., Kosiborod, M., Barrett, E. J., Ceriello, A., Isley, W. L., Mazzone, T., & Raskin, P. (2008) · Circulation · doi:10.1161/circulationaha.107.188629 · Cited by 495
Self-citationImpact of postprandial glycaemia on health and prevention of disease
Blaak, E. E., Antoine, J. M., Benton, D., Björck, I., Bozzetto, L., Brouns, F. J. P. H., Diamant, M., Dye, L., Hulshof, T. G., Holst, J. J., et al. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01011.x · Cited by 513
Obesity pandemic: causes, consequences, and solutions—but do we have the will?
Meldrum, D. R., Morris, M. A., & Gambone, J. C. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.02.104 · Cited by 457
“IR leads to higher circulating glucose, which itself increases OS (32).”
BackgroundThe Effect of Short-Term Hyperglycemia on the Innate Immune System
Jafar, N. S., Edriss, H., & NUGENT, K. M. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2015.11.011 · Cited by 479
Diabetes, hyperglycaemia, and acute ischaemic stroke
Luitse, M. J. A., Biessels, G. J., Rutten, G. E. H. M., & Kappelle, L. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70005-4 · Cited by 472
Esposito, K., Giugliano, D., Nappo, F., & Marfella, R. (2004) · Circulation · doi:10.1161/01.cir.0000134501.57864.66 · Cited by 440
Self-citationThe major inflammatory mediator interleukin-6 and obesity
Éder, K., Baffy, N. J., Falus, A., & Fulop, A. K. (2009) · Inflammation Research · doi:10.1007/s00011-009-0060-4 · Cited by 450
“In patients with impaired glucose tolerance, the IL-6 level was higher than in the healthy (but insulin secretion blocked) controls and the increased plasma level lasted longer [63].”
BackgroundDiabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 432
“Hyperglycemia is the main culprit in DR development; it affects the levels of plasma cytokines (TNF-α and IL-6) implicated in insulin resistance [26].”
BackgroundThe role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K., Jung, H., & Kim, Y. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 434
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Sardu, C., D’Onofrio, N., Balestrieri, M. L., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Paolisso, G., & Marfella, R. (2020) · Diabetes Care · doi:10.2337/dc20-0723 · Cited by 435
“Indeed, our group demonstrated that healthy subjects and patients with impaired glucose tolerance have inflammatory cytokines interleukin (IL) 6, tumor necrosis factor-a (5), and D-dimer (6) overproduction following the appearance of hyperglycemia.”
BackgroundSelf-citationA Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies
Calder, P. C., Ahluwalia, N., Albers, R., Bosco, N., Bourdet-Sicard, R., Haller, D., Holgate, S. T., Jönsson, L. S., Latulippe, M. E., Marcos, A., et al. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512005119 · Cited by 425
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
Netea, M. G., Joosten, L. A. B., Lewis, E., Jensen, D. R., Voshol, P. J., Kullberg, B. J., Tack, C. J., van Krieken, H., Kim, S.-H., Stalenhoef, A. F., et al. (2006) · Nature Medicine · doi:10.1038/nm1415 · Cited by 424
Fructose and Cardiometabolic Health
Malik, V. S., & Hu, F. B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.025 · Cited by 408
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
Song, Y., Manson, J. E., Buring, J. E., Sesso, H. D., & Liu, S. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719488 · Cited by 389
“In addition, emerging evidence shows that oxidative stress may be involved in the pathogenesis of chronic inflammation underlying insulin resistance, diabetes and cardiovascular disease [10].”
BackgroundChen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management
Kruyt, N. D., Biessels, G. J., DeVries, J. H., & Roos, Y. B. W. E. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.231 · Cited by 392
Metabolic syndrome and cardiovascular disease
Qiao, Q., Gao, W., Zhang, L., Nyamdorj, R., & Tuomilehto, J. O. (2007) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456307780480963 · Cited by 383
Microvascular complications of impaired glucose tolerance
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2867 · Cited by 372
Perioperative Hyperglycemia Management: An Update
Duggan, E. W., Carlson, K., & Umpierrez, G. E. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001515 · Cited by 402
“73 The majority of patients with an insulin pump have type 1 diabetes, but use is growing in type 2 diabetics.”
BackgroundHyperglycemia and the Pathobiology of Diabetic Complications
Aronson, D. (2008) · Advances in cardiology · doi:10.1159/000115118 · Cited by 366
Oxidative stress in environmental-induced carcinogenesis
Mena, S., Ortega, Á., & Estrela, J. M. (2008) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.09.017 · Cited by 356
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Suryavanshi, S. V., & Kulkarni, Y. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00798 · Cited by 355
“The increased ROS activates NF-κβ canonically and non-canonically that triggers NF-κβ dependent gene expression and production of pro-inflammatory cytokines IL-6, IL-10 and TNF-α in human heart (Esposito et al., 2002; Jones et al., 2003).”
BackgroundPathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Rayego‐Mateos, S., Morgado‐Pascual, J. L., Opazo-Ríos, L., Guerrero‐Hue, M., García‐Caballero, C., Vázquez‐Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 350
“Studies in patients have demonstrated that glucose administration increased IL-6 or IL-18 plasma concentration, an effect that was reduced with the antioxidant glutathione [27].”
BackgroundSit less and move more for cardiovascular health: emerging insights and opportunities
Dunstan, D. W., Dogra, S., Carter, S. E., & Owen, N. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00547-y · Cited by 333
High-fat diets, insulin resistance and declining cognitive function
Greenwood, C. E., & Winocur, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.017 · Cited by 339
“This includes a glucosenduced increase in oxidative stress, which in turn can lead o increased inflammatory cytokine [10,37] and/or cortisol f the metabolic syndrome, unless public health measures to mprove health status are effectively undertaken, incidence ates of cognitive deficits and dementia may rise.”
BackgroundZhou, X., Fragala, M. S., McElhaney, J. E., & Kuchel, G. A. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833cf3bc · Cited by 329
“Moreover the supplementation of particular antioxidants such as glutathione, vitamins E and C can attenuate the feeding-induced rise in plasma cytokines [23;24].”
BackgroundGestational Diabetes Induces Placental Genes for Chronic Stress and Inflammatory Pathways
Radaelli, T., Varastehpour, A., Catalano, P., & Hauguel-de Mouzon, S. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2951 · Cited by 390
“A causal role of hyperglycemia has been suggested in the immune activation of diabetes (46).”
BackgroundPsychosocial factors in the development of coronary artery disease
Strike, P. C., & Steptoe, A. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2003.09.001 · Cited by 316
Stress, Food, and Inflammation: Psychoneuroimmunology and Nutrition at the Cutting Edge
Kiecolt-Glaser, J. K. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181dbf489 · Cited by 310
Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes
Gunter, M. J., & Leitzmann, M. F. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.06.011 · Cited by 310
“Obesity is associated with a state of chronic inflammation, induced perhaps by excessive production of storage lipids and high circulating levels of glucose, both of which create a proinflammatory oxidative environment [70,71].”
BackgroundBonnet, F., & Scheen, A. J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.09.005 · Cited by 322
Joshi, S., Standl, E., Tong, N., Shah, P., Kalra, S., & Rathod, R. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1070827 · Cited by 314
“Moreover, PPHG increases oxidative stress [6] through endothelial dysfunction [7], and subclinical inflammation [8] that subsequently leads to development of atherosclerosis and occurrence of CV events [9].”
BackgroundOrigin and function of stress-induced IL-6 in murine models
Qing, H., Desrouleaux, R., Israni-Winger, K., Mineur, Y. S., Fogelman, N., Zhang, C., Rashed, S., Palm, N. W., Sinha, R., Picciotto, M. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.054 · Cited by 303
“Previous reports had suggested that hyperglycemia itself, a characteristic feature of the acute stress response (Esposito et al., 2002), was sufficient to induce IL6.”
Jacka, F. N., Mykletun, A., Berk, M., Bjelland, I., & Tell, G. S. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318222831a · Cited by 304
Rizzo, M. R., Barbieri, M., Marfella, R., & Paolisso, G. (2012) · Diabetes Care · doi:10.2337/dc12-0199 · Cited by 307
“Both components lead to diabetes complications through twomajor mechanisms: activation of oxidative stress and increased activity of the innate immune system (7,8).”
BackgroundSelf-citationPicard, M., McManus, M. J., Gray, J. D., Nasca, C., Moffat, C., Kopinski, P. K., Seifert, E. L., McEwen, B. S., & Wallace, D. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515733112 · Cited by 293
“, hyperglycemia) (37, 38) elevate the circulating inflammatory marker IL-6.”
BackgroundNilsson, A. C., Östman, E. M., Holst, J. J., & Björck, I. (2008) · Journal of Nutrition · doi:10.1093/jn/138.4.732 · Cited by 302
“Oxidative stress is probably a key mediator of increased cytokine concentrations and low grade systemic inflammation (8), suggesting a role in the genesis of vascular damage (9), and a possible mechanism underlying the pathophysiology of type 2 diabetes and cardiovascular disease (7,10,11).”
BackgroundCeriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., & Giugliano, D. (2005) · Circulation · doi:10.1161/01.cir.0000165070.46111.9f · Cited by 298
Self-citationThe global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Kolb, H., & Mandrup-Poulsen, T. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1573-7 · Cited by 299
“Increased activation of NFκB was found in response to glucose or a bread meal [13], and there was an increase in circulating levels of IL-6 and TNF-α during a hyperglycaemic clamp [14].”
BackgroundInfluentialRole of NF-κB in the pathogenesis of diabetes and its associated complications
Patel, S., & Santani, D. D. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70111-2 · Cited by 300
Role of Diet in Chronic Obstructive Pulmonary Disease Prevention and Treatment
Scoditti, E., Massaro, M., Garbarino, S., & Toraldo, D. M. (2019) · Nutrients · doi:10.3390/nu11061357 · Cited by 299
“In addition to increasing the risk of obesity, hyperglycemia may trigger oxidative stress-related inflammatory responses [138], is associated with impaired lung function [139] and poor COPD outcomes [140], and may promote pulmonary infection, at least in part, by an effect on airway glucose concentrations [141].”
BackgroundBlack, P. H. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.008 · Cited by 289
“interferon c and/or LPS), are also reduced during weight loss [61,88].”
BackgroundGlucose metabolism and hyperglycemia
Giugliano, D., Ceriello, A., & Esposito, K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.217s · Cited by 284
Self-citationNutrition, inflammation and liver-spleen axis
Barrea, L., Somma, C. D., Muscogiuri, G., Tarantino, G., Tenore, G. C., Orio, F., Colao, A., & Savastano, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1353479 · Cited by 317
“2005), have been extensively evaluated (Esposito et al. 2002; Steckhan et al. 2016; Feliciano Pereira, das Graças de Almeida, and Alfenas Rde 2014).”
BackgroundInfluentialHyperglycemia Exacerbates Brain Edema and Perihematomal Cell Death After Intracerebral Hemorrhage
Song, E.-C., Chu, K., Jeong, S., Jung, K., Kim, S. H., Kim, M., & Yoon, B. (2003) · Stroke · doi:10.1161/01.str.0000088060.83709.2c · Cited by 263
Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin
Piya, M. K., McTernan, P. G., & Kumar, S. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0498 · Cited by 266
“(Esposito et al. 2002) and IL6 in non-diabetic and T2DM subjects (Ruge et al.”
BackgroundMallone, R., Mannering, S. I., Brooks‐Worrell, B., Durinovic‐Belló, I., Cilio, C., Wong, F. S., & Schloot, N. C. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04272.x · Cited by 261
Li, L., Luo, W., Qian, Y., Zhu, W., Qian, J., Li, J., Jin, Y., Xu, X., & Liang, G. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.034 · Cited by 264
Oxidative stress as a therapeutic target in diabetes: revisiting the controversy
Wiernsperger, N. F. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70072-1 · Cited by 260
“In glucose-intolerant (IGT) subjects, the increased level of inflammatory cytokines is linked to oxidative processes [57].”
BackgroundNew insights into insulin: The anti-inflammatory effect and its clinical relevance
Sun, Q., Li, J., & Gao, F. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.89 · Cited by 253
Inflammageing and metaflammation: The yin and yang of type 2 diabetes
Prattichizzo, F., Nigris, V. D., Spiga, R., Mancuso, E., Sala, L. L., Antonicelli, R., Testa, R., Procopio, A. D., Olivieri, F., & Ceriello, A. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.003 · Cited by 255
“Post-prandial hyperglycaemia is known to be associated with a transient pro-inflammatory response in both humans and mice (Dror et al., 2017; Esposito et al., 2002).”
Self-citationDaniele, G., Guardado‐Mendoza, R., Winnier, D. A., Fiorentino, T. V., Zuo, P., Cornell, J. E., Andreozzi, F., Jenkinson, C. P., Cersósimo, E., Federici, M., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0543-1 · Cited by 252
“Although the relation between glycemic instability and the risk of cardiovascular disease and diabetic complications is complex, it has been demonstrated that repeated fluctuations of glucose produce increased circulating levels of inflammatory cytokines compared with stable high glucose in normal subjects and worsene…”
BackgroundMechanisms underlying the effect of polysaccharides in the treatment of type 2 diabetes: A review
Wu, J., Shi, S., Wang, H., & Wang, S. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.02.040 · Cited by 244
Al-Waili, N. S. D. (2004) · Journal of Medicinal Food · doi:10.1089/109662004322984789 · Cited by 242
“28 Honey compared with dextrose reduced PGL and insulin in normal subjects.”
Hung, J., McQuillan, B., Chapman, C., Thompson, P. L., & Beilby, J. P. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163843.70369.12 · Cited by 240
Chronic stress impacts the cardiovascular system: animal models and clinical outcomes
Golbidi, S., Frisbee, J. C., & Laher, I. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00859.2014 · Cited by 262
“secretion of inflammatory mediators possibly through an oxidative mechanism (86).”
Schulze, M. B., Rimm, E. B., Shai, I., Rifai, N., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1680 · Cited by 235
“Hyperglycemia acutely increases circulating cytokine concentrations (38,39).”
‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting
Ceriello, A., & Ihnat, M. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02967.x · Cited by 236
Self-citationNarain, A., Kwok, C. S., & Mamas, M. A. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12841 · Cited by 223
Diet and inflammation: a link to metabolic and cardiovascular diseases
Esposito, K., & Giugliano, D. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi605 · Cited by 236
“These findings are in line with previous studies demonstrating that after oral or intravenous glucose challenges, in both normal subjects and patients with type 2 diabetes mellitus, there is an increased generation of ROS and raised circulating levels of inflammatory cytokines, such as tumour necrosis factor-a (TNF-a)…”
ResultSelf-citationZhao, Y., Banerjee, S., Dey, N., LeJeune, W. S., Sarkar, P. S., Brobey, R. K. B., Rosenblatt, K. P., Tilton, R. G., & Choudhary, S. (2011) · Diabetes · doi:10.2337/db10-1262 · Cited by 232
“Our rationale for selecting TNF-a as a diabetic milieu inflammatory stimulus was based on clinical and epidemiological data indicating a role for TNF-a in the initiation and progression of diabetes, including the following: 1) proinflammatory cytokines such as IL-6, TNF-a, IL-1b, and plasminogen activator inhibitor-1…”
MethodDiNicolantonio, J. J., Bhutani, J., & O’Keefe, J. H. (2015) · Open Heart · doi:10.1136/openhrt-2015-000327 · Cited by 243
“39 Further, Esposito et al 40 showed that in individuals with both normal (n=20) and IGT (n=15) intravenous glucose pulses caused a signi fi cantly greater increase in mediators of subclinical in fl ammation (interleukin-6 and tumour necrosis factor-α ) as compared to sustained hyperglycaemic periods.”
ResultMantzoros, C. S., Li, T., Manson, J. E., Meigs, J. B., & Hu, F. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0372 · Cited by 224
“Finally, the associations reported in this study are consistent with a large and accumulating body of evidence (20, 32, 33) on the role of adiponectin in metabolism and inflammation, but some weak associations, albeit statistically significant due to the high power of the study, may not be as clinically important.”
BackgroundResultHyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition
Cheung, N. W., Napier, B., Zaccaria, C., & Fletcher, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2367 · Cited by 221
Cytokines as Biomarkers in Rheumatoid Arthritis
Burska, A. N., Boissinot, M., & Ponchel, F. (2014) · Mediators of Inflammation · doi:10.1155/2014/545493 · Cited by 231
“Several methods of detection (ELISA, immunohistochemistry) identified TNF-alpha and IL-1 as major players in the network of cytokines, notably directly expressed at the disease site in joint tissue or fluid.”
BackgroundPatel, C., Ghanim, H., Ravishankar, S. T., Sia, C. L., Viswanathan, P., Mohanty, P., & Dandona, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0778 · Cited by 221
Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., & Makino, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2890 · Cited by 218
“Activation of nuclear factor- B through oxidative stress induced by hyperglycemia increases concentrations of circulating proinflammatory cytokines (2).”
BackgroundCritical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Rosak, C., & Mertes (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s28340 · Cited by 221
“The increased formation of adhesion molecules and increased adhesion of monocytes to endothelial cells leads to formation of thrombotic plaques.(17,18) At the same time, hyperglycemia increases the formation of cytokines and C-reactive protein.”
Guideline for management of postmeal glucose
Ceriello, A., Colagiuri, S., Gerich, J. E., & Tuomilehto, J. O. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.01.012 · Cited by 211
Self-citationProspective study of dietary patterns and chronic obstructive pulmonary disease among US women
Varraso, R., Fung, T. T., Barr, R. G., Hu, F. B., Willett, W. C., & Camargo, C. A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.488 · Cited by 212
“[27] Furthermore, both hyperglycemia and COPD are positively related to inflammation,[28, 29] even if the causal association between COPD and the systemic inflammation remains unclear.”
BackgroundObesity: Genes, brain, gut, and environment
Das, U. N. (2009) · Nutrition · doi:10.1016/j.nut.2009.09.020 · Cited by 212
Nutritionally Mediated Oxidative Stress and Inflammation
Muñoz, A. B., & Costa, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/610950 · Cited by 215
“Acute hyperglycemia results in elevated levels of circulating inflammatory cytokines including TNFα, IL-6, and IL-18 and more extreme responses in these parameters are observed when glucose spikes; this response is attenuated by administration of glutathione confirming the presence of an oxidative stress-related mecha…”
BackgroundAbdominal obesity and metabolic syndrome: exercise as medicine?
Paley, C. A., & Johnson, M. I. (2018) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-018-0097-1 · Cited by 217
“which might contribute to a chronic inflammatory state [28].”
Baker, E. H., Clark, N., Brennan, A. L., Fisher, D. A., Gyi, K. M., Hodson, M. E., Philips, B. J., Baines, D. L., & Wood, D. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01425.2006 · Cited by 200
“657 FEV1/FVC ratio, % 51 (12) 61 (12) 0.”
Metadata
- Authors
- Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D.
- Affiliations
- University of Udine (IT)
- Venue
- Circulation
- Published
- 2002-10-15
- Volume
- 106
- Issue
- 16
- Pages
- 2067-2072
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2123560318
- Cited by
- 1,961
- References
- 36
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 88 · 2023: 95 · 2022: 106 · 2021: 91 · 2020: 102 · 2019: 83 · 2018: 86 · 2017: 70 · 2016: 87 · 2015: 112 · 2014: 99 · 2013: 102 · 2012: 101
- FWCI
- 38.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, inflammatory cytokines, interleukin-6, TNF-α, IL-18, impaired glucose tolerance, glutathione, oxidative stress, glucose clamp
- MeSH terms
- Adult, Antioxidants, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glutathione, Humans, Inflammation, Kinetics, Male, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Glucose Intolerance, Oxidative Stress, Interleukin-18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review